The Coronavirus Treatment Acceleration Program (CTAP) is a special emergency program instituted by the US Food and Drug Administration (FDA) in response to the COVID-19 pandemic. The primary goal of the program is to expedite the availability of new treatments and vaccines to COVID-19 patients as rapidly as possible by using every possible resource, applicable pathway, and process across the agency. Download this special feature to learn more.


Download our special feature